NasdaqCM - Delayed Quote • USD
AxoGen, Inc. (AXGN)
At close: April 18 at 4:00 PM EDT
After hours: April 18 at 5:13 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | -0.07 | -0.04 | -0.16 | 0.17 |
| Low Estimate | -0.16 | -0.07 | -0.32 | -0.04 |
| High Estimate | -0.02 | -0.01 | 0.03 | 0.59 |
| Year Ago EPS | -0.1 | -0.03 | -0.17 | -0.16 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 41.96M | 43.61M | 179.51M | 202.48M |
| Low Estimate | 41.5M | 43M | 179M | 200M |
| High Estimate | 42.9M | 44.1M | 180.5M | 204.8M |
| Year Ago Sales | 36.66M | 38.16M | 159.01M | 179.51M |
| Sales Growth (year/est) | 14.40% | 14.30% | 12.90% | 12.80% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.14 | -0.13 | -0.06 | -0.1 |
| EPS Actual | -0.1 | -0.03 | 0.01 | -0.06 |
| Difference | 0.04 | 0.1 | 0.07 | 0.04 |
| Surprise % | 28.60% | 76.90% | 116.70% | 40.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.07 | -0.04 | -0.16 | 0.17 |
| 7 Days Ago | -0.07 | -0.04 | -0.16 | 0.17 |
| 30 Days Ago | -0.07 | -0.04 | -0.16 | 0.17 |
| 60 Days Ago | -0.02 | -0.01 | -0.07 | 0.28 |
| 90 Days Ago | -0.02 | -0.01 | -0.07 | 0.28 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AXGN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 30.00% | -- | -- | 0.80% |
| Next Qtr. | -33.30% | -- | -- | 9.60% |
| Current Year | 5.90% | -- | -- | 4.50% |
| Next Year | 206.20% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -53.59% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/19/2024 |
| Reiterates | Canaccord Genuity: Buy to Buy | 12/7/2023 |
| Initiated | Leerink Partners: Outperform | 10/16/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/26/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/22/2023 |
| Reiterates | JMP Securities: Market Outperform | 5/10/2023 |
Related Tickers
OFIX Orthofix Medical Inc.
13.02
+0.15%
FNA Paragon 28, Inc.
9.65
-0.82%
NPCE NeuroPace, Inc.
14.00
+1.82%
AFIB Acutus Medical, Inc.
0.1745
+6.99%
CVRX CVRx, Inc.
15.26
-2.86%
BVS Bioventus Inc.
4.5500
-3.19%
ELUT Elutia Inc.
3.0500
+2.87%
ESTA Establishment Labs Holdings Inc.
52.57
+0.81%
ATEC Alphatec Holdings, Inc.
12.34
-1.36%
LIVN LivaNova PLC
52.76
+1.72%